In vitro inhibition of cytosolic carbonic anhydrases I and II by some new dihydroxycoumarin compounds

References

• Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors. Curr Med Chem-Imm Endoc Metab Agents 2001; 1: 61–97
   Google Scholar
• Thiry A, Dogné JM, Masereel B, Supuran CT. Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends Pharmacol Sci 2006; 27: 566–573
   PubMed Web of Science ®Google Scholar
• McKierman JM, Buttyan R, Stifelman MD, Kutz AG, Chen MW, Olsson CA, Sawczuk IS. Expression of tumor-associated gene MN: A potential biomarker of human renal cell carcinoma. Cancer Res 1997; 57: 2362–2365
   PubMed Web of Science ®Google Scholar
• Tureci O, Sahin O, Vollmar E, Siemer S, Gottert E, Seitz G, Parkkila AK, Shah GN, Grubb JH, Pfreundschuh M, Sly WS. Human carbonic anhydrase XII: cDNA cloning, expression and chromosomal localization of a carbonic anhydrase gene that is over expressed in some renal cancers. Proc Natl Acad Sci USA 1998; 95: 7608–7613
   PubMed Web of Science ®Google Scholar
• Parkkila S, Rajaniemi H, Parkkila AK, Kivelä J, Waheed A, Pastorekova S, PAstorek J, Sly WS. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci 2000; 97: 2220–2224, USA
   PubMed Web of Science ®Google Scholar
• Teicher BA, Liu SD, Liu JT, Holden SA, Herman TS. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anti Cancer Res 1993; 13: 1549–1556
   PubMed Web of Science ®Google Scholar
• Ozensoy O, Puccetti L, Fasolis G, Arslan O, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of the tumor associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides. Bioorgan Med Chem Lett 2005; 15(21)4862–4866
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003; 23: 146–189
   PubMed Web of Science ®Google Scholar
• Bayram T, Arslan O, Ugras HI, Cakır U, Ozensoy O. Purification of carbonic anhydrase from dog erytrocytes and investigation of in vitro inhibition effects by various compounds. J Enz Inhib Med Chem 2007, in press
   PubMed Web of Science ®Google Scholar
• Khan KM, Szaify ZS, Khan M, Ullah Z, Choudhary IM, Rahman AU, Perveen S, Chohan ZH, Supuran CT. Synthesis of coumarin derivatives with cytotoxic, antibacterial and antifungal activity. J Enz Inhib Med Chem 2004; 19(4)373–379
   PubMed Web of Science ®Google Scholar
• Rehman SU, Chohan ZH, Gulnaz F, Supuran CT. In-vitro antibacterial, antifungal and cytotoxic activities of somecoumarins and their metal complexes. J Enz Inhib Med Chem 2005; 20(4)333–340
   PubMed Web of Science ®Google Scholar
• Budzisz E. Synthesis, reactions and biological activity of phosphorus-containing derivatives of chromone and coumarin. Phosphorus, sulfur and silicon and the related elements. 2004; 179(10)2131–2147(17)
   Google Scholar
• Iscan M, Rostami H, Güray T, Pelkonen O, Rautio A. Interindividual variability of coumarin 7-hydroxylation in a turkish population. Eur J Clin Pharmacol 1994; 47(4)315–318
   PubMed Web of Science ®Google Scholar
• Cakir U, Ozer M, Icen MA, Ugras HI, Bulut M. Synthesis of some 3-phenyl chromenone-crown ethers and equilibrium studies on complexation with ion-pair extraction of sodium and potassium dyes. Dyes Pigments 2004; 60: 177–185
   Web of Science ®Google Scholar
• Buu-Hoi NP, Saint-Ruf G, Lobert B. Oxygen heterocycles. Part XIV. Hydroxylated 3-aryl-and 3-pyridyl-coumarins. J Chem Soc C 1969; 16: 2069
   Google Scholar
• Ozensoy O, Arslan O, Oznur Sinan S. A new method for purification of carbonic anhydrase isozymes by affinity chromatography. Biochemistry (Moscow) 2004; 69: 216–219
   PubMed Web of Science ®Google Scholar
• Isık S, Kockar F, Ozensoy O, Arslan O. Carbonic anhydrase from cyprinus carpio fresenius. Envir Bull 2004; 13(1)25–29
   Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inhibitors and activators and their use in therapy. Expert Opin Ther Pat 2006; 16: 1627–1644
   Web of Science ®Google Scholar
• Mc Intosh J. Carbonic anhydrase isoenzymes in the erythrocytes and dorsolateral prostate of the rat. J Biochem 1969; 14: 463–467
   Web of Science ®Google Scholar
• Gamboa J, Caceda R, Gamboa A, Monge-C C. Carbonic anhydrase activity in the red blood cells of sea level and high altitude natives. Biol Res 2000; 33(3–4)207–208
   PubMed Web of Science ®Google Scholar
• Supuran CT, Briganti F, Tilli S, Chegwidden WR, Scozzafava A. Carbonic anhydrase inhibitors: Sulfonamides as antitumor agents?. Bioorg Med Chem 2001; 9(3)703–714
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin Ther Pat 2000; 10(5)575–600
   Web of Science ®Google Scholar
• Okamoto T, Kobayashi T, Yoshida S. Chemical aspects of coumarin compounds for the prevention of hepatocellular carcinomas current medicinal chemistry - anti-cancer agents. 2005; 5: 47–51
   Google Scholar
• Leese MP, Leblond B, Smith A, Newman SP, Di Fiore A, De Simone G, Supuran CT, Purohit A, Reed MJ, Potter BV. 2-Substituted estradiol bis-sulfamates, multitargeted antitumor agents: Synthesis, in vitro SAR, protein crystallography, and in vivo activity. J Med Chem 2006; 49: 7683–7696
   PubMed Web of Science ®Google Scholar
• Vullo D, Franchi M, Gallori E, Antel J, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of mitochondrial Isozyme V with Aromatic and heterocyclic sulfonamides. J Med Chem 2004; 47: 1272–1279
   PubMed Web of Science ®Google Scholar
• Cakir U, Ugras HI, Ozensoy O, Sinan S, Arslan O. In vitro effects of some new sulfonamide Inhibitors on human carbonic anhydrase I and II. J Enz Inhib Med Chem 2004; 19(3)257–261
   PubMed Web of Science ®Google Scholar
• Menchise V, Simone De G, Fiore A Di, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2- sulfonamide to human isoform II. Bioorg Med Chem Lett 2006; 16(24)6204–6208
   PubMed Web of Science ®Google Scholar
• Nishimori I, Innocenti A, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Inhibition studies of the human secretory isoform VI with anions. Bioorg Med Chem Lett 2007; 17(4)1037–1042
   PubMed Web of Science ®Google Scholar
• Temperini C, Innocenti A, Scozzafava A, Supuran CT. N-Hydroxyurea—A versatile zinc binding function in the design of metalloenzyme inhibitors. Bioorgan Med Chem Lett 2006; 16: 4316–4320
   PubMed Web of Science ®Google Scholar
• Srinivasa RN, Mallireddigari MR, Cosenza S, Gumireddy K, Bell SC, Prekumar RE, Ramana RMV. Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activity. Bioorg Med Chem Lett 2004; 14(15)4093–4097
   PubMed Web of Science ®Google Scholar
• Zobel AM, Schellenberger SE. Paclitaxel in combination with coumarin as a potentially effective anticancer agent. Pharm Biol 2000; 38(3)192–196
   PubMed Web of Science ®Google Scholar
• Simonsson I, Jonsson BH, Lindskog S. Phenol, a competitive inhibitor of CO2 Hydration catalyzed by carbonic anhydrase. Biochem Biophys Res 1982; 108(4)1406–1412
   PubMed Web of Science ®Google Scholar